본문 바로가기 주메뉴 바로가기
국회도서관 홈으로 정보검색 소장정보 검색

결과 내 검색

동의어 포함

초록보기

OBJECTIVE Ambulatory care sensitive conditions (ACSC) refer to conditions such as diabetes and hypertension that can be effectively treated in outpatient settings. We evaluated the impact of depression on primary care outcomes by assessing the risk of hospitalization for ACSC (H-ACSC) in patients with depression. METHODS We utilized the 2018 Health Insurance Review and Assessment Service-National Patients Sample (HIRA-NPS) data. Patients with depression were defined as those with at least two claim records with a primary diagnosis of depression (International Classification of Diagnosis (ICD)-10th codes: F32-F33) or prescription of antidepressants. Patients without depression were those without claim records and prescription. The hospitalization rate of ACSC was compared between these two groups. RESULTS About 1.38% (n=13,653) of adult patients from the 2018 HIRA-NPS had depression. Patients with depression had about two times higher risk of H-ACSC (adjusted odds ratio (aOR): 1.992, 95% confidence interval (CI): 1.775-2.235) than those without depression. Among those experiencing H-ACSC, patients with depression had 1.184 times more inpatients days per year (aOR: 1.184, 95% CI: 1.060-1.323) and 1.472 times higher chances of having total annual inpatient days more than the 75 percentile of the patients hospitalized with ACSC (aOR: 1.472, 95% CI: 1.159-1.871). Respiratory, circulatory, and genitourinary diseases accounted for 80% of H-ACSC cases across both groups among the eight ACSC diseases analyzed. CONCLUSION Our analysis confirms that depression is associated with an elevated risk of H-ACSC. Without proper monitoring of depression in ACSC patients, the effectiveness of primary care in managing ACSC may be compromised.

권호기사

권호기사 목록 테이블로 기사명, 저자명, 페이지, 원문, 기사목차 순으로 되어있습니다.
기사명 저자명 페이지 원문 목차
Assessment of the excess risk of avoidable hospitalization for ambulatory-care sensitive conditions in patients with depression = 우울증 환자의 외래진료 민감 질환으로 인한 입원의 위험 평가 : 전국 인구 기반 연구 : a population-based national study Yekyong Kim, Hye-Young Kang p. 15-23
해외 유명인 언급과 소셜 미디어를 통해 발생한 국내 대중의 비만치료제 관심도와 반응 분석 = Analysis of domestic public interest and reactions to obesity medications driven by international celebrity mentions and social media 황지현, 김성옥, 이지원, 한은아 p. 24-31
중증질환 치료제의 접근성 강화 = Enhancing access to medicines through the named patient approach and dedicated funding : insights from France, Scotland, and Australia : 개별환자접근방식과 별도기금 도입의 필요성 권혜영 p. 1-14
국내 항생제 사용관리 프로그램의 최적화 방향에 대한 제언 = Suggestions for optimizing the antimicrobial stewardship program in South Korea : with reference to ASP initiatives in the US and Japan : 미국 및 일본의 사례를 참고하여 김도연, 김조안, 윤지용, 정지수, 홍송희 p. 32-44
의료용 마약류 빅데이터(NIMS)를 활용한 의료용 마약류 약물의 처방 경향 및 처방량 관련 요인 분석 = Analysis of prescription patterns and factors related to prescription volume of medical narcotics using the narcotics information management system (NIMS) 안은지, 하동문, 이의경 p. 45-52